Silverback Therapeutics Inc (SBTX)

Track

Stock chart
Ticker: SBTX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-20 2025-06-18 PS Planned sale

Karas Eric

Chief Commercial Officer

Officer
1,000 -66.1%
16.00
USD 240,000 		1,000 -66.1% 16.00 USD 100,000
2025-05-22 2025-05-20 S Sale

SAUNDERS BRENT L

Non-Executive Director
120,000 -100.0%
14.25
USD 1,710,024 		120,000 -100.0% 14.25 USD 1,710,024
2025-05-22 2025-05-20 S Sale

Scott Kathleen D.

Chief Financial Officer

Officer
50,000 -87.1%
14.10
USD 705,165 		50,000 -87.1% 14.10 USD 705,165
2025-05-22 2025-05-20 S Sale

Fitzpatrick Alexander A

Chief Legal Officer

Officer
102,969 -53.5%
14.10
USD 1,451,513 		102,969 -53.5% 14.10 USD 1,451,513
2025-04-08 2025-04-07 PS Planned sale

Shawver Laura

Non-Executive Director
50,002 -19.2%
12.30
USD 615,075 		50,002 -19.2% 12.30 USD 615,075
2025-03-21 2025-03-20 PS Planned sale

Karas Eric

Chief Commercial Officer

Officer
10,000 -56.5%
14.00
USD 140,000 		10,000 -56.5% 14.00 USD 140,000
2025-03-07 2025-03-06 PS Planned sale

Shawver Laura

Non-Executive Director
49,600 -19.1%
11.21
USD 556,046 		49,600 -19.1% 11.21 USD 556,046
2025-03-07 2025-03-05 PS Planned sale

Shawver Laura

Non-Executive Director
400 -0.2%
11.00
USD 4,400 		400 -0.2% 11.00 USD 4,400
2025-02-04 2025-02-03 PS Planned sale

Shawver Laura

Non-Executive Director
50,000 -19.2%
12.31
USD 615,565 		50,000 -19.2% 12.31 USD 615,565
2025-01-07 2025-01-06 PS Planned sale

Shawver Laura

Non-Executive Director
50,000 -19.2%
11.10
USD 555,065 		50,000 -19.2% 11.10 USD 555,065
2024-12-19 2024-12-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
USD 583,525 		50,000 -4.4% 11.67 USD 583,525
2024-12-19 2024-12-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
USD 583,575 		50,000 -3.7% 11.67 USD 583,575
2024-12-19 2024-12-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
USD 583,525 		50,000 -4.4% 11.67 USD 583,525
2024-12-19 2024-12-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
USD 583,575 		50,000 -3.7% 11.67 USD 583,575
2024-12-13 2024-12-13 S Sale

Chakma Justin

Chief Business Officer

Officer
27,272 -16.7%
12.06
USD 328,969 		27,272 -16.7% 12.06 USD 328,969
2024-12-13 2024-12-12 S Sale

Dorsey Brian

Chief Operating Officer

Officer
25,000 -80.6%
12.30
USD 307,433 		25,000 -80.6% 12.30 USD 307,433
2024-12-13 2024-12-12 S Sale

Chakma Justin

Chief Business Officer

Officer
117,333 -46.2%
12.27
USD 1,439,124 		117,333 -46.2% 12.27 USD 1,439,124
2024-12-13 2024-12-11 PS Planned sale

Dorsey Brian

Chief Operating Officer

Officer
15,000 -71.3%
12.43
USD 186,426 		15,000 -71.3% 12.43 USD 186,426
2024-12-12 2024-12-10 S Sale

Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
13.15
USD 657,625 		50,000 -26.8% 13.15 USD 657,625
2024-12-11 2024-12-10 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
USD 658,155 		50,000 -4.2% 13.16 USD 658,155
// ... existing code ...